Candide cream 1%, 20 g
Category
Antifungal
Scope of the drug
Leather
,
Dermatology
Release form
Cream
Manufacturer country
India
Package quantity, pcs
one
Candide cream 1% 20g
Name ENG
CANDID
Clinical and pharmacological group
Antifungal drug for external use
ATX code
Clotrimazole
Dosage
1% x 20g
Structure
1 g of cream contains: Active ingredient: clotrimazole 10 mg Excipients: propylene glycol
liquid paraffin
cetomacrogol emulsion wax
white petroleum jelly
benzyl alcohol
methylparaben
propylparaben
anhydrous sodium phosphate
sodium phosphate monobasic
butylhydroxytoluene
purified water.
Indications
dermatophytosis of the head (including face), body, legs
mycosis of nails
versicolor versicolor
candidiasis of the skin
candidal paronychia
candidal vulvitis
candidal balanitis
candidiasis of the external genital organs and the anus
fungal diaper dermatitis
erythrasma.
Storage conditions and periods
In a dark place at a temperature of 2-25 degrees.
Expiration date: 4 years
INN / Active ingredient
Clotrimazole
Contraindications
specific skin lesions (including tuberculosis, chickenpox, herpes simplex, measles, syphilis)
skin reactions at the vaccination site
hypersensitivity to drug components.
Specifications
Category
Antifungal
Scope of the drug
Leather
,
Dermatology
Release form
Cream
Manufacturer country
India
Package quantity, pcs
one
Scope of application
Dermatology
Way of introduction
Outwardly
,
Locally
Vacation conditions
Without recipe
Brand name
Glenmark Pharmaceuticals LTD IN
,
Glenmark
The amount of the dosage form in the primary package
20 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Antifungal agent
Anatomical and therapeutic characteristics
D01AC01 Clotrimazole
Dosage form
Cream for external use
Packaging
Box
Expiration date in days
1095
The target audience
Adult
Dosage (volume) of the substance in the preparation
clotrimazole 10 mg
Package weight, g
thirty
Mode of application
:
The required amount of cream is rubbed onto the previously washed and dry affected skin area 2-3 times a day.
< br> Treatment should be continued for another 2-4 weeks after the disappearance of clinical symptoms in order to ensure mycological cure and prevent relapse.